Fri, October 13, 2023
Thu, October 12, 2023
Wed, October 11, 2023
Tue, October 10, 2023
Mon, October 9, 2023

David Risinger Upgraded (AMGN) to Buy and Increased Target to $318 on, Oct 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. nd-increased-target-to-318-on-oct-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Risinger of Leerink Partners, Upgraded "Amgen Inc." (AMGN) to Buy and Increased Target from $267 to $318 on, Oct 11th, 2023.

David has made no other calls on AMGN in the last 4 months.



There are 9 other peers that have a rating on AMGN. Out of the 9 peers that are also analyzing AMGN, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Robyn Karnauskas of "Truist Securities" Reiterated at Hold and Held Target at $260 on, Tuesday, September 5th, 2023
  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $223 on, Monday, August 14th, 2023
  • Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $253 on, Friday, August 4th, 2023


These are the ratings of the 6 analyists that currently disagree with David


  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $290 on, Monday, October 9th, 2023
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $280 on, Monday, September 18th, 2023
  • Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $320 on, Wednesday, September 6th, 2023
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Increased Target to $310 on, Monday, August 14th, 2023
  • Trung Huynh of "Credit Suisse" Maintained at Buy with Decreased Target to $200 on, Wednesday, July 12th, 2023
  • Carter Gould of "Barclays" Maintained at Sell with Decreased Target to $210 on, Tuesday, July 11th, 2023

Publication Contributing Sources